- Report
- July 2026
- 702 Pages
Global
From €4411EUR$4,799USD£3,760GBP
- Report
- September 2026
- 195 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- October 2026
- 179 Pages
Global
From €5378EUR$5,850USD£4,583GBP
- Report
- November 2025
- 182 Pages
Global
From €4137EUR$4,500USD£3,526GBP
- Report
- May 2026
- 400 Pages
Global
From €3557EUR$3,869USD£3,031GBP
- Report
- April 2026
- 146 Pages
Global
From €3676EUR$3,999USD£3,133GBP
- Report
- July 2026
- 120 Pages
Global
From €4366EUR$4,750USD£3,721GBP
- Report
- October 2025
- 114 Pages
Global
From €3631EUR$3,950USD£3,095GBP
- Report
- February 2026
- 185 Pages
Global
From €4458EUR$4,850USD£3,800GBP
- Report
- February 2026
- 100 Pages
Africa, Middle East
From €4411EUR$4,799USD£3,760GBP
- Report
- September 2026
- 653 Pages
Global
From €4411EUR$4,799USD£3,760GBP
- Report
- October 2026
- 177 Pages
Global
From €5378EUR$5,850USD£4,583GBP
- Report
- April 2026
- 401 Pages
Global
From €4550EUR$4,950USD£3,878GBP
- Report
- July 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP
- Report
- September 2026
- 182 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 180 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- September 2026
- 190 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- January 2026
- 193 Pages
Global
From €3259EUR$3,545USD£2,777GBP
€3621EUR$3,939USD£3,086GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,518GBP

The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety.
Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more